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ZebraﬁshPantothenate Kinase Associated Neurodegeneration (PKAN) is an autosomal recessive disorder with mutations
in the pantothenate kinase 2 gene (PANK2), encoding an essential enzyme for Coenzyme A (CoA) biosynthesis.
The molecular connection between defects in this enzyme and the neurodegenerative phenotype observed in
PKAN patients is still poorly understood. We exploited the zebraﬁsh model to study the role played by the
pank2 gene during embryonic development and get new insight into PKAN pathogenesis. The zebraﬁsh
orthologue of hPANK2 lies on chromosome 13, is a maternal gene expressed in all development stages and, in
adult animals, is highly abundant in CNS, dorsal aorta and caudal vein. The injection of a splice-inhibiting
morpholino induced a clear phenotype with perturbed brain morphology and hydrocephalus; edema was pres-
ent in the heart region and caudal plexus, where hemorrhages with reduction of blood circulation velocity were
detected. We characterized the CNS phenotype by studying the expression pattern of wnt1 and neurog1 neural
markers and by use of the Tg(neurod:EGFP/sox10:dsRed) transgenic line. The results evidenced that downregu-
lation of pank2 severely impairs neuronal development, particularly in the anterior part of CNS (telencephalon).
Whole-mount in situ hybridization analysis of the endothelial markers cadherin-5 and ﬂi1a, and use of
Tg(ﬂi1a:EGFP/gata1a:dsRed) transgenic line, conﬁrmed the essential role of pank2 in the formation of the vascu-
lar system. The speciﬁcity of the morpholino-induced phenotype was proved by the restoration of a normal de-
velopment in a high percentage of embryos co-injected with pank2mRNA. Also, addition of pantethine or CoA,
but not of vitamin B5, to pank2 morpholino-injected embryos rescued the phenotype with high efﬁciency. The
zebraﬁshmodel indicates the relevance of pank2 activity and CoAhomeostasis for normal neuronal development
and functioning and provides evidence of an unsuspected role for this enzyme and its product in vascular
development.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Pantothenate Kinase-Associated Neurodegeneration (PKAN, OMIM
ID: 234200) is themost common form of a group of inherited neurolog-
ical disorders named Neurodegeneration with Brain Iron Accumulation
(NBIA) (Hayﬂick et al., 2003; Levi and Finazzi, 2014). PKAN is an autoso-
mal recessive disease that usually manifests in early childhood with
dystonia, spasticity and pigmentary retinopathy (Hayﬂick, 2014; Kruerolecular and Translationa
escia, Italy.
ario.ﬁnazzi@unibs.it
ect.com).
. This is an open access artilcle underet al., 2011), and often proceeds in a stepwise neuroregressionwith loss
of motor skills, cognitive decline and premature death; in a minority of
atypical cases there is a later onset and the progression is much slower
(Kurian and Hayﬂick, 2013). A distinctive diagnostic sign is the detec-
tion of the “eye of the tiger” on T2*-weightedmagnetic resonance imag-
ing, i.e. a bilateral areas of hyperintensity within a region of
hypointensity in the medial globus pallidus (Hayﬂick, 2003). A recent
histological study on genetically-conﬁrmed cases demonstrated that
this brain region is severely affected, showing iron accumulation, signif-
icant neural loss and abundant spheroidal structures (Kruer et al.,
2011). Disease-causing mutations were found in the Pantothenate Ki-
nase 2 gene (PANK2) (Zhou et al., 2001); the encoded enzyme catalyzes
the phosphorylation of pantothenate (vitamin B5), ﬁrst and limiting
step in the CoA biosynthesis pathway. The other PANK proteinsthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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cells and tissues, but show important differences in termsof sub-cellular
compartmentalization, regulation and expression. In particular human
PANK2 is ubiquitous, but highly expressed in the brain (Zhou et al.,
2001; Leonardi et al., 2007a), and localizes in the mitochondrial inter-
membrane space (Hörtnagel et al., 2003; Johnson et al., 2004;
Kotzbauer et al., 2005) and possibly in the nucleus (Alfonso-Pecchio
et al., 2012), whereas the other paralogs are predominantly found in
the cytosol of cells (Alfonso-Pecchio et al., 2012), where most of CoA
biosynthetic process happens. Furthermore, hPANK2 is particularly sen-
sitive to feedback inhibition by acetyl-CoA (IC50 = 0.1 μM), but can be
activated by long-chain acyl-carnitines (Leonardi et al., 2007b; Vallari
et al., 1987). On the basis of these features it was suggested that it
may function as a sensor for mitochondrial CoA requirement and regu-
lator of CoA biosynthesis. The discovery that many PANK2 mutants
show normal catalytic activity, at least in vitro (Kotzbauer et al., 2005;
Zhang et al., 2006), challenges the simplest hypothesis of a shortage of
cellular CoA, that has never been documented in patients andﬁbroblasts
frompatients or inmousemodels of the disease. Nonetheless, a growing
body of evidence indicates that perturbation of CoA homeostasis is the
key factor in disease development, and the identiﬁcation of mutations
in another enzyme of this biochemical pathway, COASY, in two patients
with NBIA further strengthen this notion (Dusi et al., 2014). This is par-
ticularly evident in the Drosophila model of the disease, where the re-
duced levels of expression of the only dPANK/Fbl enzyme results in
reduced CoA levels, locomotor dysfunction and neurodegeneration
with severe morphological alterations of mitochondria (Bosveld et al.,
2008; Rana et al., 2010). An almost complete rescue of the phenotype
observed in the hypomorphmutant dPANK/fbl is obtained by a “substitu-
tion therapy”, that is feeding animals with pantethine (Rana et al., 2010).
Pantethine feeding is also effective in ameliorating the diseased pheno-
type observed in Pank2−/−mice exposed to a ketogenic diet (Brunetti
et al., 2014). Studies in animal and cellular models of the disease also
provided important information about the cellular processes that may
be affected when PANK2 function is defective. They evidenced perturba-
tion of mitochondriamorphology and functionality (Bosveld et al., 2008;
Rana et al., 2010; Brunetti et al., 2014; Siudeja et al., 2011; Brunetti et al.,
2012), increased oxidative stress and perturbed iron homeostasis (Poli
et al., 2010; Campanella et al., 2012; Santambrogio et al., 2015), alter-
ation of tubulin and histones acetylation (Siudeja et al., 2012). Yet the
molecular connection between such phenomena is poorly deﬁned and
many fundamental questions about the existing relationship among
PANK2, CoA metabolism and neurodegeneration remain unanswered.
Zebraﬁsh possesses a single ortholog of PANK2 together with three
other paralogs (pank1a, pank1b and pank4) and could represent a rele-
vant tool to study pank2 function in different tissues and its role during
embryonic development. Here we describe an in-depth morpho-
functional characterization of the gene in zebraﬁsh and provide func-
tional insights of potential relevance for PKAN pathology in humans.
2. Materials and methods
2.1. Bioinformatic analysis
Identiﬁcation of pantothenic acid kinase family members in zebraﬁsh
was initially performedbyquerying theGene andHomoloGenedatabases
at NCBI [PMID: 25398906]. More detailed genome sequence analysis
were carried out using the University of California Santa Cruz (UCSC) Ge-
nome Browser (http://genome.ucsc.edu/) on the Zv9 (July 2010) Danio
rerio assembly, with data validated also on the more recent (Sep. 2014)
Zv10 release. In our bioinformatic investigations we also used the
Ensembl zebraﬁsh genome database (http://www.ensembl.org/Danio_
rerio/Info/Index). Synteny analysis was achieved using both the
Genomicus synteny browser [PMID: 20185404] and the Synteny Data-
base [PMID: 19465509]. Nucleotide and amino acid sequenceswere com-
pared to the non-redundant sequence databases present at the NCBI(National Center for Biotechnology Information) using the Basic Local
Alignment Search Tool (BLAST) [PMID: 2231712]. Multiple sequence
alignment was performed using ClustalW algorithm [PMID: 7984417].
Phylogenetic analysis was carried out with the Phylogeny.fr web service
[PMID: 18424797] as follows: sequences were aligned with T-Coffe, am-
biguous regions (i.e. containing gaps and/or poorly aligned) were re-
moved with Gblocks, the phylogenetic tree was reconstructed using the
maximum likelihood method implemented in the PhyML program and
tree rendering obtained with TreeDyn. The GenBank accession numbers
of the amino acid sequences used for multiple sequences alignment and
phylogenetic analysis are listed in Table ST1 (supplementary informa-
tion). Protein subcellular localization prediction was performed using
TargetP [PMID: 10891285] and Wolf PSORT [PMID: 17517783]
algorithms.
2.2. Fish breeding, embryo collection and treatments
Wild type zebraﬁsh AB strain or the transgenic lines Tg(−2.4 Kb
neurod:EGFP), hereinafter named Tg(neurod:EGFP) (Casari et al.,
2014), Tg(−2.4 Kb neurod:EGFP-sox10:dsRed) abbreviated as
Tg(neurod:EGFP-sox10:dsRed) (Kucenas et al., 2008), Tg(gata1a:dsRed)
(Traver et al., 2003) and Tg(gata1a:dsRed-ﬂi1a:EGFP) (Lawson and
Weinstein, 2002) were used for the experiments. They were all kept in
tanks containing 3–5 l of water at 28 °C on 14 h light/10 h dark cycle
(Westerﬁeld et al., 1990). Adult zebraﬁsh were bred by natural crosses
and collected embryos were staged according to Kimmel et al. (1995).
Embryos were raised at 28 °C in ﬁsh water (0.1 g/l Instant Ocean Sea
Salts, 0.1 g/l sodium bicarbonate, 0.19 g/l calcium sulfate, 0.2 mg/l
methylen blue, H2O) until the desired developmental stagewas reached.
To examine post-gastrulation stages, regular ﬁsh water was replaced by
0.0045% PTU (1-phenil-2-thiourea, Sigma) solution. The embryos were
dechorionated by hand using sharpened forceps and then ﬁxed in 4%
(wt/vol) paraformaldehyde 1× PBS overnight at 4 °C (or 2 h at room
temperature), into 2-ml tubes, dehydrated through sequential washes
in 25%, 50%, 75%methanol/PBS, 100%methanol and stored at least over-
night at−20 °C. The oldest age at which the zebraﬁsh embryos were
sacriﬁced is 96 hours post fertilization (hpf). Euthanasia of embryos
has been carried out by prolonged immersion in tricainemethane sulfo-
nate (400 mg/l). To ensure death, bleach solution (6.15% sodium hypo-
chlorite) was added at 1 part bleach to 5 parts water.
To determine the effects of pantethine, CoA and vitamin B5 (Sigma)
upon embryos development, the speciﬁc drugwas added directly in the
ﬁsh-water 2 or 5 hpf (blastula or gastrula developmental stage); dose-
curve experiments were performed with concentrations ranging from
20 to 500 μM and the morphology observed at 24 and 48 hpf. Heart
beat rate was determined by direct counting in at least 10 different em-
bryos from 6 microinjection experiments.
Although current Italian rules (Art. 7 D.L. 116/92 and Art. 8 22/04/
1994) do not require a formal approval for biomedical research on
zebraﬁsh embryos, a project entitled “Utilizzo dell'embrione del pesce
teleosteo D. rerio – zebraﬁsh – per lo studio di patologie umane” (Use
of the teleost ﬁsh D. rerio – zebraﬁsh – for the study of human disease)
has been presented on 8/10/2010 and approved by the Ministero del
Lavoro, della Salute e delle Politiche Sociali (Ministry of Labour, Health
and Social Policy). The approval has been renewed after a new request
submitted on 10/10/2013. The Zebraﬁsh Centre in Padova is working
under the approval Prot. 12489, 20/02/2013, from the University of Pa-
dova Ethics Committee for Animal Experimentation (Project 74 BIS/
2012: “Use of Zebraﬁsh – D. rerio – as a model for vertebrate develop-
ment and human pathology”). On the whole, animal experiments
were carried out according to the EU Directive 2010/63/EU.
2.3. RNA extraction and real time PCR
Total RNA was extracted from 30 embryos for each different devel-
opmental stage analyzed, frozen in liquid nitrogen, using TRI-Reagent
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adult ﬁshes were killed by an excess of ethyl 3-aminobenzoate
methanesulfonate salt solution (Sigma). RNA was quantiﬁed using the
My Spect spectrophotometer (Biomed) and controlled by electropho-
retic separation on a 1% TAE-agarose gel. 1.0 μg of total RNA was
retro-transcribed to cDNA using Im-Prom reverse transcriptase
(Promega) and oligo(dT) primers following the manufacturer's proto-
col. Primers were designed by the PrimerQuest and Real Time PCR
Tool from IDT (see Table ST2 in supplementary information). Real-
Time PCR was performed using the Eco-Illumina system. Reactions
were performed in a 10 μl volume, with 100 μM of primer P1 and P2
for pank2 and A1 and A2 for actb1, 12.5 μl of Syber Green Master Mix
(Biorad) and 20 ng of cDNA. The ampliﬁcation proﬁle consisted of a de-
naturation program (95 °C for 1 min), 40 cycles of two steps ampliﬁca-
tion (95 °C for 15 s and 60 °C for 30 s) followed by a melting cycle. Each
reaction was performed in triplicate andwhen possible actin beta 1was
used as a reference gene. Relative levels of expression were calculated
by the ΔΔCT method and with respect to the 2-cell stage.
2.4. pank2 cDNA isolation and expression in mammalian cells
The full length pank2 cDNA was ampliﬁed by RT-PCR from the RNA
obtained from the 2-cell stage with Pfu DNA polymerase (Promega)
and the primers P3 and P4 (Table ST2). The P3 primer was designed to
add the FLAG-tag sequence at the 3′ of pank2 cDNA. The ampliﬁed prod-
uctwas digestedwithNheI e BamHI and subcloned in the pcDNA3.1 vec-
tor digested with the same restriction enzymes. Automated DNA
sequencing of the recombinant construct conﬁrmed the sequence of
the cloned insert. Cos7 andHeLa cellswere cultured inDMEM(PAA Lab-
oratories) supplemented with 10% fetal bovine serum (Euroclone),
1 mM L-glutamine and 40 μg/ml gentamicin. SH-SY5Y cells were cul-
tured in Minimal Essential Medium/Ham's F-12 (PAA Laboratories)
with 10% fetal bovine serum, 40 μg/ml gentamicin and 1 mM L-gluta-
mine. For transfection, 105 cells were seeded in chambers mounted on
glass slides and after 24 h exposed to 1.0 μg of pcDNA-pank2-FLAG
cDNA and 3.0 μl of ViaFect reagent (Promega) according to
manufacturer's instructions. 24–48 h after transfection the cells were
eventually incubated with Mitotracker (Life Technologies) 25 nM, for
10 min in DMEM without FBS and then washed three times with PBS,
ﬁxed in 4% paraformaldehyde in PBS for 10 min at room temperature
and permeabilized with PBS/0.1% Triton-X100 at 4 °C for 15 min. Cells
were incubated for 30 min in wash medium (PBS/5% BSA) and then
with anti-FLAG primary antibody (1:300, Sigma) diluted in PBS/1%
BSA for 16 h. After three washes in wash medium they were incubated
with anti-mouse secondary antibody conjugated to the ﬂuorescent dye
AlexaFluor 488 (1:300, Life Technologies) for 1 h,washed three times in
wash medium and once with PBS alone. Coverslips were then mounted
with aqueous mounting medium (Sigma) and analyzed at the
microscope.
2.5. Riboprobes synthesis and whole-mount in situ hybridization
To synthesize the riboprobes for the detection of zebraﬁsh pank2
transcripts, we ampliﬁed speciﬁc regions by PCR using as template the
cDNA from the 2-cell stage and oligonucleotide primers P5-P6 and P7-
P8. The ampliﬁcation conditions were the following: 2 min at 95 °C,
30 cycles at 94 °C for 30 s, 60 °C for 30 s, 72 °C for 1 min, followed by
ﬁnal extension at 72 °C for 5 min. The PCR products were subcloned
with the pGEM-T-Easy system (Promega), and veriﬁed for sequence
and orientation of the inserts. Antisense and sense RNAprobeswere ob-
tained by in vitro transcription of the cloned cDNAs with T7 or SP6 RNA
polymerase, using a digoxigenin labeling mixture according to
manufacturer's instructions (Roche). Whole-mount in situ hybridiza-
tion (WISH) was performed according to a standard method (Thisse
and Thisse, 2008). Brieﬂy, embryos and larvae were collected,
dechorionated and incubated at 28 °C at different stages. Embryoswere ﬁxed overnight in 4% paraformaldehyde (PFA) at 4 °C, dehydrated
through an ascendingmethanol series and stored at−20 °C. After treat-
ment with proteinase K (10 μg/ml, Roche), the embryos were hybrid-
ized overnight at 68 °C with DIG-labeled antisense or sense RNA
probes (400 ng). Embryos were washed with ascending scale of Hybe
Wash/PBS and SSC/PBS, then incubated with anti-DIG antibody conju-
gated with alkaline phospatase over night at 4 °C. The stainingwas per-
formed with NBT/BCIP (blue staining solution, Roche) alkaline
phosphatase substrates. When different type of probes (sense vs
antiense) or ﬁsh (injected vs not-injected) had to be compared, all incu-
bationswere carried out at the same time, at the same probe concentra-
tion and, when possible, with the same reagents and solutions. WISH
images were taken with a Leica MZ16F stereomicroscope equipped
with DFC 480 digital camera and LAS Leica Imaging software (Leica).
Magniﬁcation: 50×, 63×, and 80×.
2.6. Staining with acridine orange and anti-phosphohistone H3 antibody
Acridine orange (AO) staining is a nucleic acid selective metachro-
matic stain technique that can identify cell death (Perkins et al., 2005).
For AO staining, embryos at 2 dpf were in vivo dechorionated and incu-
bated for 30 min in ﬁsh water containing acridine orange at 10 mg/l.
Embryos were then rinsed three times in ﬁsh water, anesthetized with
tricaine, positioned in 2% methyl cellulose and quickly imaged under a
dissectingmicroscopewith green ﬂuorescentﬁlter. For cell proliferation
analysis, we exploited the mitosis-speciﬁc marker phosphohistone H3
(PHH3) (Hendzel et al., 1997). After PFA-ﬁxation andmethanol storage,
embryoswere rehydrated and incubated two times in PBST (PBS/1% Tri-
ton X-100), one time in distilled water and 7 min in acetone at−20 °C.
After one wash in distilled water and one wash in PBST, embryos were
pre-incubated in PBDT (PBS + 1% BSA + 1% DMSO + 0.5% Triton X-
100) plus 2% goat serum (Sigma G9023), and then incubated over
night at 4 C in PBDT/goat serum containing a rabbit anti-PPH3 antibody
(1:1000, Merck Millipore 06-570). After four washes, 15 min each, in
PBDT, embryos were incubated over night at 4 °C in PBDT containing a
goat anti-rabbit AP-conjugated antibody (1:1000, Merck Millipore 12-
448). After four washes, 15 min each, in PBDT, embryos were stained
by NBT/BCIP protocol, post-ﬁxed in PFA and mounted in 87% glycerol/
PBS for documentation.
2.7. Microinjections
To knock-down the expression of Pank2 protein, the P2-MO splice-
blocking morpholino (GeneTools, LCC) was synthesized targeting the
exon1-intron1 boundary (Table ST2). Different amounts of morpholino
were initially injected intowild type embryos (Fig. S4), to determine the
optimal concentration of 1 pmol/embryo as the one appropriate for
these experiments and with no toxic effects. A standard control
morpholino oligonucleotide (ST-MO) was used as negative control
(Table ST2). The morpholinos were injected in 1× Danieau buffer
(pH 7.6) into 1-to 2-cell stage embryos and the dye tracer rhodamine
dextran was also co-injected as previously reported (Nasevicius and
Ekker, 2000). After microinjection, embryos were incubated in ﬁsh
water supplemented with 0.003% PTU at 28 °C to prevent pigmentation
processes. Embryo development was evaluated at 24 hpf, 48 hpf, and
72 hpf. RT-PCR experiments were performed on RNA extracted from
24 hpf and 48 hpf P2-MO- or ST-MO-injected and wild type embryos,
with P9 and P10 primers to demonstrate the absence of a functional
gene transcript in morphants. Control RT-PCR ampliﬁcation on the
same RNA was carried out with eef1a1l1 primers (EF1 and EF2,
Table ST2).
2.8. Production of pank2 synthetic mRNA for morpholino phenotype rescue
The coding region of the pank2 gene was ampliﬁed by PCR using P9
and P10 primers (ST1) with Pfu DNA polymerase (Promega). The PCR
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tor digested with the same restriction enzymes. The plasmid was
checked for the sequence and then digested with PvuII restriction en-
zyme; the insert containing the pank2 cDNA was gel-puriﬁed and tran-
scribed with SP6 RNA polymerase using the mMESSAGE mMACHINE
SP6 in vitro transcription kit (Ambion) according to the manufacturer's
instructions. Dose–response curve experimentswere performed inwild
type embryos to identify the maximum amount of pank2 mRNA that
does not induce phenotypic alterations. The rescue of the morphant
phenotype was obtained by co-injecting 1 pmol/embryo of P2-MO to-
gether with 50 pg/embryo of synthetic pank2-mRNA. The presence of
the synthetic mRNA was also conﬁrmed by an RT-PCR performed on
injected embryos at 24 hpf with pank2 (P11 and P12, Table ST2) and
eef1a1l1 speciﬁc primers.
2.9. Microscopy and confocal imaging
For transverse sectioning, post in situ embryos were embedded in
gelatin/BSAmedium (0.4% Type A porcine skin gelatin, 27% BSA, 18% su-
crose in 1× PBS), plus 1.75% glutaraldehyde. The gelatin blocks were
sectioned (30 μm) in PBS using a Leica VT1000S vibratome. The slice
weremounted in ImmunoHistoMount (Sigma) and imagedwith a com-
pound Leica DMR microscope, equipped with Nomarski optics and a
DC500 Leica digital camera. Fluorescence of transgenic lines was visual-
ized using a Leica M165FC dissecting microscope and then a Nikon C2
H600L confocal microscope. For in vivo analyses, embryos and larvae
were anesthetized with tricaine 0.16 mg/ml and mounted in 1% low
melting agarose gel. EGFP and Red ﬂuorescence was visualized by
using 488 and 561 nm lasers, respectively, through 20× and 40× im-
mersion objectives (Nikon). All images were analyzed with Nikon and
Volocity 6.0 (Perkin Elmer) software.
2.10. Statistical analysis
The data are reported as the mean +/− SD values or as representa-
tive of at least three independent experiments with similar results. Sta-
tistically signiﬁcant differences between different types of embryos
were calculated by one-way ANOVA analyses; *, ** indicated pb b 0.05,
pb b 0.01 respectively.
3. Results
3.1. Identiﬁcation and characterization of zebraﬁsh pank2 gene
The Gene and HomoloGene databases at NCBI indicate a single
zebraﬁsh ortholog of the human PANK2 gene. D. rerio pank2 (Gene ID:
570866) is also present in the ZFIN database with the following ID:
ZDB-GENE-070112-1952. It is located on chromosome 13 and similarly
to the human counterpart, is organized in seven exons and harbors the
miR-103 gene within the ﬁfth intron (data not shown). The analysis of
the genomic region surrounding pank2, carried out using the Synteny
Database, allowed to identify conserved synteny between human chro-
mosome 20 and D. rerio chromosome 13 (Supplementary information,
Fig. S1A). Similar results have been obtained using the Genomicus
synteny browser (data not shown). pank2 encodes a protein of 437 aa
(RefSeq NP_001074075.2) that is highly conserved in vertebrates, and
homologous sequences can be found in lower eukaryotic and prokary-
otic organisms. A multiple sequence alignment among PANK2 polypep-
tides from man, mouse, chicken and zebraﬁsh (Fig. S1B) indicates a
high level of identity among the four polypeptides, with the exception
of the ﬁrst 124 amino acids at the N-terminus of the human sequence,
here represented by the mitochondrial isoform 1 preproprotein
(NP_705902). In a local alignment analysis zebraﬁsh Pank2 shows 72%
and 77% identity to the human and mouse polypeptides, respectively.
A phylogenetic analysis, carried out including all the pantothenic acid
kinases identiﬁed in the four vertebrates considered for the multiplesequence alignment, shows that theD. rerio protein under investigation
correctly segregates in the PANK2 clade (Fig. S1C). RNA-Seq data from
theWellcome Trust Sanger Institute Zebraﬁsh Transcriptome Sequenc-
ing Project indicate that pank2 is transcribed throughout development
and in adult ﬁsh (data not shown) [PMID: 22798491]. The presence of
RNA-Seq reads from 2-cell stage embyos indicates that the gene is ma-
ternally expressed. Data inferred from Expression Sequence Tag (EST)
proﬁle provide evidence that the gene is particularly expressed in the
brain of adult ﬁsh.
Zebraﬁsh pank2ORFwas subcloned in pcDNA3.1 vector with a 3′ se-
quence extension coding for the FLAG epitope tag. Cos7 and HeLa cells
were transfected with the plasmid and the distribution of the ﬂag-
tagged protein analyzed by immunoﬂuorescence. In transfected cells
we detected a diffuse staining, presumably cytosolic often associated
with a nuclear signal, as evidenced by DAPI co-staining (Fig. S2). We
did not ﬁnd any evident overlap with the mitochondrial marker
Mitotracker.
3.2. Developmental expression of zebraﬁsh pank2 gene
To study pank2 gene expression and distribution during zebraﬁsh
embryonic development, we carried outWISH experiments at different
developmental stages: 4-cell, 30% epiboly, 18-somite stage, 24 and
48 hpf. Two different regions of the pank2 mRNA were ampliﬁed by
RT-PCR, cloned in pGEM-T vector and the sequence was conﬁrmed.
The plasmids were then used to synthesize the speciﬁc digoxigenin-
labeled antisense and sense riboprobes by in vitro transcription with
T7 or SP6 RNA polymerase. To assess the speciﬁcity of hybridizations,
sense probeswere used inparallel andwith the same experimental con-
ditions; no staining was detected in any embryo at all stages (Fig. S3A,
B). The WISH performed with two different antisense riboprobes re-
vealed that pank2 is a maternal gene, expressed in zygotes and at
early stages of development (epiboly) (Fig. 1A–C). During
somitogenesis a more deﬁned expression pattern appeared in the ros-
tral part of the embryo at the level of the developing central nervous
system (CNS). At 24 hpf pank2 is transcribed in deﬁned structures
such as forebrain, midbrain and cerebellum (Fig. 1D); at 48 hpf pank2
continues to be mainly expressed in the central nervous system but it
also appears in vascular structures such as the axial vein, the dorsal
aorta and the caudal plexus (Fig. 1E). Hystological sections of embryos
hybridized with pank2 riboprobe were performed at 24 and 48 hpf, re-
vealing intense signals localized in the ependymal layer of the CNS and
in the epidermis. In parallel, we analyzed pank2 expression by real time
qRT-PCR performed with 20 ng of cDNA from different developmental
stages (Fig. S3C) and adult tissues (Fig. S3D). The analysis shows highest
levels of the transcript at the 1/2-cell stage, conﬁrming that the pank2
gene is maternally expressed. pank2 mRNA partially drops at lower
levels in the initial hours of development and raises back to higher
values at 48 and 72 hpf. In adult animals, the pank2 transcript is
expressed at the highest level in the brain and in the eyes. Overall the
analysis suggests a role for pank2 in CNS early differentiation and func-
tion and possibly also in vasculogenesis and/or angiogenesis.
3.3. Morphological investigation of the phenotype induced by pank2 down-
regulation
To investigate the function of pank2 gene during zebraﬁsh develop-
ment we designed an antisense morpholino-oligotargeting the exon 1/
intron 1 boundary of the gene (P2-MO). A standardmorpholinowith an
unrelated sequence (ST-MO, Gene-Tools) was used as control in all ex-
periments. Both morpholinos were injected at one/two-cell stage and
embryos were collected at the indicated developmental stages. Dose
curve experiments were performed to set the optimal concentration
of 1 pmol/embryo (Fig. S4A). Normally, 85% of P2-MO-injected embryos
survived (n = 232/276), compared to 99% of control embryos injected
with ST-MO (n = 282/286). The RT-PCR analysis of pank2 morphants
Fig. 1.Developmental expression of zebraﬁsh pank2.WISHwasperformed from1 to 48hpf using a pank2-speciﬁc, DIG-labeled antisense probe of 625 bp. From the “cleavageperiod” to the
somitogenesis the pank2 signal is diffuse (A, B, C). At 24hpf the transcript is present in deﬁned CNS regions (midbrain, hindbrain andmidbrain–hindbrain boundary). At 48hpf the signal in
the brain region is still present and also appears in themain vessels and in vessels of the vascular plexus in the tail region (E). A, B, C dorsal view, D and E lateral view, anterior to the left.
Cross-sections at the level of the head and trunk of 24 (F, G) and 48 hpf embryos (H). Abbreviations: m, midbrain; mhb, midbrain–hindbrain boundary; h, hindbrain; da, dorsal aorta: cv;
cardinal vein; pcv, post cardinal vein; e, epidermis; el, ependymal layer. The ﬁgure shows representative images from at least three different experiments, with 20 embryos/stage.
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morpholino. A band corresponding to the endogenous pank2 transcript
was clearly detected in non-injected and control-injected embryos,
while the expected band was reduced by 65% (P b 0.01) in P2-MO-
injected embryos (Fig. 2E, F). To evaluate possible interference of the
morpholino upon expression of other pank paralogs, we quantiﬁed
pank1a and pank1bmRNA levels by RT-PCR at 2-cell and 24 hpf stages
in control and P2-MO-injected embryos, without detecting any differ-
ence among the analyzed samples (Fig. S4B). Then, we carefully com-
pared the morphology of P2-MO-injected embryos at 24 and 48 hpf
with that of non-injected and control ones. A summary of themain phe-
notypic features is presented in Table 1. At 24 hpf P2-MO-injected em-
bryos showed clear abnormalities in the development of CNS and
vascular structures. The brain structures were not well-deﬁned, with a
clear reduction of the hindbrain (Fig. 2A, B). A nascent edema was evi-
dent in heart region and caudal plexus (Fig. 2B’). The phenotype was
more evident at 48 hpf, when a signiﬁcant percentage (73%, n = 209/
283) of embryos showed abnormal head development with smaller
eyes and hydrocephalus in the midbrain and hindbrain ventricle. Addi-
tionally, we could often observe reduction of the antero-posterior axis
and presence of edema in the cardiac region. The heart rate was signif-
icantly reduced, with amean of 120 bpm in control ﬁsh vs 85 in P2-MO-
injected embryos (Fig. S5) and blood circulation appeared to be slower
at the visual observation (not shown). The caudal plexus was irregular
and hemorrhagic (Fig. 2C, D, D’). Altogether the analysis of embryosfrom 6 differentmicroinjection of a speciﬁc pank2-morpholino revealed
a clear phenotype, with speciﬁc perturbation of central nervous and
vascular system, suggesting the requirement for pank2 expression in
normal development of these tissues and organs in zebraﬁsh..
To validate the cause–effect relationship between lack of pank2 and
the phenotype observed in P2-MO-injected embryos, we performed
phenotypic/functional rescue experiments by co-injection of P2-MO
and exogenous pank2-mRNA. While the single injection of high doses
of pank2mRNA (500–200 pg/embryo) resulted in signiﬁcant abnormal-
ities and high mortality (N90%, not shown), the dose of 50 pg/embryo
was not lethal and did not induce signiﬁcant morphological changes
when co-injected with the ST-MO or alone (not shown); on the con-
trary, co-injection of 50 pg of exogenous mRNA with 1 pmol/embryo
of P2-MOwas able to restore thewild type phenotype in 71% of injected
embryos (n = 108/152, in a total of 5 microinjection) (Fig. 3A–E). The
efﬁcacy of the mRNA micro-injection was monitored by a speciﬁc RT-
PCR, that revealed a signiﬁcant increase of pank2mRNA on injection of
exogenous mRNA (Fig. 3D).
PANK2 is a relevant enzyme in CoA biosynthesis and defects in its
functioning have been successfully reverted in cellular and animal
models by pantethine supplementation in culture medium or in diet
(Rana et al., 2010; Brunetti et al., 2014). When added to ﬁsh-water,
pantethine showed signiﬁcant toxicity at doses higher than 50 μM
(Fig. S6A). Addition of pantethine at 30 μM at 5 hpf (gastrula stage) re-
stored the wild type phenotype in a large percentage (81%) of P2-MO-
Fig. 2. Effects of pank2morpholino during zebraﬁsh development. Standard (ST-MO) and pank2morpholino (P2-MO)weremicro-injected at 1/2-cell stage (1 pmol/embryo) and the phe-
notype observed at 24 and 48 hpf. At both developmental stages, morphants showed abnormalities in the brain region, presence of hydrocephalus (*) and heart edema (≠) (D), severe
perturbation of main vessels (dorsal aorta and caudal vein) and vascular plexus in the tail (arrowhead andmagniﬁcation B’, D’). E) Semi-quantitative RT-PCR analysis of pank2 transcript
levels in non-injected (CNT), ST-MO- and P2-MO-injected embryos at 24 and 48 hpf. F) Densitometric analysis of RT-PCR products resolved by agarose-gel electrophoresis. * = P b 0.001.
G) Quantitative analysis of the phenotype observed in P2-MO-injected embryos at 48 hpf. Two different phenotypes could be distinguished: a severe one (12%)with headmalformations,
presence of hydrocephalus and evident edema in the caudal plexus, severe defects in anterior-posterior axis and delay in development; a milder phenotype (59%) with not well-deﬁned
brain areas, less severe hydrocephalus and edema in caudal plexus. The graph shows the analysis performed in six independent experiments on a total of 562 injected embryos. Abbre-
viations: hv, hindbrain ventricle, h, hindbrain, m, midbrain, mhb, midbrain–hindbrain boundary.
40 D. Zizioli et al. / Neurobiology of Disease 85 (2016) 35–48injected embryos (n = 126/156, out of 3 microinjections) at 24 hpf
(Fig. S6B), without affecting efﬁcacy of the injected morpholino (not
shown). Most embryos injected with P2-MO and treated with
pantethine showed no perturbation of brain morphology and no vascu-
lar alteration and signs of edema in the caudal plexus at 24 hpf and
48 hpf, and were very similar to non-injected and ST-MO injected em-
bryos (Fig. 4). On the contrary, 50 μMvitamin B5 did not affect themor-
phology shown by P2-MO-injected embryos (Fig. S7).
Addition of CoA to the growth medium of Drosophila Schneider's S2
cells depleted of dPANK/Fbl was able to restore normal levels of protein
acetylation, apparently by replenishing intracellular CoA stores (Siudeja
et al., 2011). Since zebraﬁsh embryos are easily permeable to small mol-
ecules and largely used for high-throughput screening of chemical com-
pounds (Tan and Zon, 2011), we decided to directly verify whether CoA
itself added to ﬁsh-water could prevent the aberrant development due
to pank2 down-regulation. CoA had some toxic effect on zebraﬁsh em-
bryos only at concentrations higher than 500 μM (data not shown).
100 μM CoA was added to the water of embryos two hours after
morpholino injection, and the phenotype was observed at 48 hpf.
While most embryos exposed only to P2-MO showed the usualTable 1
Main morphological alterations observed in P2-MO-injected embryos.
Morphological defects 24 hpf 48 hpf
Altered brain morphology +++ +++
Edema in hindbrain–midbrain ventricle (hydrocephalus) + +++
Edema in the caudal plexus + +++
Reduced heart beating rate + +++
Reduced blood circulation + ++
+++= strong alteration, ++=moderate alteration, + =mild alteration.phenotype with hydrocephalus and edema of heart and tail, the vast
majority (82%) of the embryos (n = 87/105 out of 3 microinjection)
also treated with CoA had a normal phenotype, similar to that of ST-
MO-injected embryos (Fig. 5). These results suggest that down-
regulation of pank2 can lead to a shortage of CoA in speciﬁc cells and tis-
sues in zebraﬁsh embryos, that can be compensated bymetabolites en-
tering the CoA biosynthetic pathway downstream of panthotenate
phosphorylation (pantethine, CoA). At the same time, they suggest
that other pank paralogs cannot compensate for pank2 downregulation
in affected tissues.
3.4. Molecular characterization of the neural phenotype in P2-MO-injected
embryos
To gain further insights into themolecular alterations accompanying
the CNS phenotype observed after suppression of pank2, we investigat-
ed the developmental expression pattern ofwnt1 and neurog1 byWISH.
wnt1 is a factor required for maintenance of expression of several genes
in the midbrain–hindbrain boundary (Lekven et al., 2003). Our data
showed that about 70% (n = 38/54, 2 microinjections) of pank2
morphants had a signiﬁcant down-regulation of wnt1 expression at
24 hpf (Fig. 6A, B).
Next, we analyzed the expression pattern of ngn1, a key transcrip-
tion factor for zebraﬁsh neurogenesis, and an upstream regulator of
neurod (Mueller and Wullimann, 2002); it is initially expressed in the
neural plate and at later stages it is detectable in tegmentum, dorsal di-
encephalon, posterior midbrain, midbrain–hindbrain boundary, hind-
brain area, optic stalk and spinal cord. At 24 hpf we observed a
substantial reduction and partial disorganization of ngn1 staining in an-
terior brain areas (including tegmentum, diencephalon and hindbrain)
Fig. 3. Rescue of the pank2 knock-down phenotype by co-injection of zebraﬁsh pank2mRNA. Lateral views of ST-MO- (A), P2-MO- (B) and P2-MO/pank2mRNA-injected embryos (C) at
24 hpf. D) Gel electrophoresis of RT-PCR products for pank2 and eef1a1l1mRNAs performed on described samples. The ﬁgure shows a representative experiment out of ﬁve with similar
results. E) The graph shows the statistical analysis result from the morphological evaluation of embryos.
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injections). Additionally at 48 hpf, a down-regulation in dorsal hind-
brain and midbrain–hindbrain boundary was observed in more than
90% of pank2morphants when compared to controls (Fig. 6D, E, G, H).
Then, we treated transgenic ﬂuorescent-reporter lines Tg
(neurod:EGFP) and Tg (neurod:EGFP-sox10:dsRed) with either ST-MO
or P2-MO. neurod, as neurog1, is a key transcription factor for zebraﬁsh
neurogenesis (Mueller and Wullimann, 2002). At 24 hpf it is expressedFig. 4. Rescue of the pank2 knock-down phenotype by pantethine. Morphological comparison o
with pantethine 30 μM (C, F) at 24 and 48 hpf. A high percentage of embryos exposed to pante
plexus (arrowheads) and hydrocephalus (asterisk).in telencephalon, diencephalon, symmetric primordial of trigeminal
ganglia, olfactory placode and caudally in spinal cord. The sox10:dsRED
transgene has been included in the analysis as internal control, in order
to simultaneously monitor cranial neural crest derivatives (Kague et al.,
2012). In vivomorphological analysis revealed in P2-MO-injected trans-
genic embryos the same alterations observed inwild type embryoswith
disorganization of CNS structures, presence of hydrocephalus in mid-
brain and hindbrain ventricle and smaller otic vesicles (Fig. 7A). Atf ST-MO- (A, D) and P2-MO-injected embryos (B, E)with P2-MO-injected embryos treated
thine showed correction of the aberrant phenotype, with absence of edema in the caudal
Fig. 5. CoA administration allows normal development in P2-MO-injected embryos. Morphological comparison at 48 hpf of ST-MO- (A, B) and P2-MO-injected embryos (C, D) with P2-
MO-injected embryos treatedwith 100 μMCoA (E, F). Themagniﬁcation of heads (A–E) and tails (B–F) of representative embryos is shown. Addition of CoA to ﬁsh-water at blastula stage
prevents all morphological alterations observed in embryos upon pank2 down-regulation.
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pression was severely diminished when compared to control embryos
(Fig. 8B). This was conﬁrmed by higher magniﬁcation analyses per-
formed on transgenic line Tg(neurod:EGFP-sox10:dsRed) injected with
P2-MO (n=35/48),where the number of neurod-positive cells in telen-
cephalon and dorsal diencephalon was strongly reduced and the hind-
brain ventricle was not well deﬁned. On the contrary, we did not
observe signiﬁcant variation in sox10 expression. (Fig. 7C, D). Taken to-
gether the results further conﬁrm the essential role for pank2 for anteri-
or CNS normal development in zebraﬁsh.
The altered phenotype observed in P2-MO-injected embryoswas as-
sociated with a signiﬁcant increase in number of cell death events as
assessed by AO staining (Fig. 8). The presence of dead cells was particu-
larly evident in the forebrain but in general it seemed to overlap with
the distribution of morphological alterations in morphants. Zebraﬁsh
embryoswere then stainedwith an antibody recognizing the phosphor-
ylated form of histoneH3 (PHH3), amarker formitotic nuclei. No signif-
icant differences were observed among non-injected-, ST-MO- and P2-
MO-injected embryos (Fig. S8) as conﬁrmed by direct counting ofpositive nuclei performed in the same region analyzed for quantiﬁcation
of cell death events. Overall, these data suggest that the neural pheno-
type observed in pank2 deﬁcient embryos is mainly associated to an in-
creased rate of cell death in the forebrain region rather than a decrease
of cell proliferation in the same anatomical area.
3.5. Injection of P2-MO causes defects in vascular integrity
A more in-depth analysis of the consequences of pank2 suppression
upon development of the vascular system was performed by in situ hy-
bridization experiments using a cadherin 5 speciﬁc probe (Montero-
Balaguer et al., 2009). This vascular endothelial cadherin is a key protein
in early stages of vascular development, being involved in maintenance
of inter-cellular junctions in endothelial cells, important structures for
control of vascular permeability to cells and plasma proteins and also
for correct architecture of vascular network. Embryos were injected
with 1 pmol/embryo of P2-MO and analyzed at 24 hpf. At these devel-
opmental stages, about 75% (n = 39/52, out of 2 microinjections) of
the injected embryos showed a signiﬁcant down-regulation of the
Fig. 6. Expression of neuralmarkers is affected in P2-MO-injected embryos. The expression of the neuralmarkerswnt1 (A, B) and ngn1 (C–H)was analyzed in ST-MO- and P2-MO-injected
embryos by WISH with speciﬁc probes. A, B, E, H dorsal views; C–F lateral views. Abbreviations: dd, dorsal diencephalon; tel., telencephalon; tg, tegmentum; mhb, midbrain–hindbrain
boundary; hb, hindbrain; dh, dorsal hindbrain.
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intersomitic branches sprouting from them (Fig. 9).
Very similar results were obtained using another endothelial-
vascular marker: ﬂi1a. At 26 hpf pank2morphants hybridized with the
ﬂi1a riboprobe showed a signiﬁcant alteration in the formation of inter-
segmental vessels (Fig. 10A, A’, B, and B’). We injected the P2-MO in the
double transgenic ﬁsh line Tg(gata1a:dsRed-ﬂi1a:EGFP) that expresses
dsRed and EGFP proteins under gata1a and ﬂi1a promoter, respectively.
Gata1 is a zinc-ﬁngered transcription factor necessary for terminal dif-
ferentiation of erythroid, eosinophilic and mast cell lines (Cantor,
2005); hence it is a tool for detecting organs responsible for blood cell
production and erythrocytes (Long et al., 1997); Fli1a is a crucial tran-
scription factor for vascular development (Liu et al., 2008), being
expressed in the endothelial precursors, which develop into cranial,
axial and intersegmental blood vessels. We analyzed injected embryos
at 48 hpf by confocal microscopy. In the vast majority of P2-MO-
injected embryos (n = 52/73, 71%, out of 2 microinjections) we ob-
served a partial disorganization of intersegmental vessels and malfor-
mation of the aorta and cardinal vein. A signiﬁcant delay in
establishment of anastomosis between contiguous intersegmental ves-
sels was evident; several vessels lacked connection with the rest of vas-
culature and presented altered lumen and signs of initial regression
(Fig. 10C, D). Blood ﬂow is important in formation of stable vessels
that integrate in a functional network and seems to be required in cer-
tain vessels (ISVs) for opening of vascular lumen. In P2-MO-injected
embryos we observed an altered distribution of red cells, suggesting asigniﬁcant disorganization of endothelial cells and dysmorphic vascular
lumen (Fig. 10C, D). The difference in shape of red blood cells (dsRed
positive) in controlﬁsh (rod-like) andmorphants (round) can be attrib-
uted to the drastic reduction of blood ﬂow velocity in P2-MO-injected
ﬁsh. The results were conﬁrmed by confocal microscope analysis at
80 hpf of transgenic ﬁsh Tg(gata1a:dsRed) and Tg(ﬂi1a:EGFP) where
we also observed the presence of hemorrhages in head and heart re-
gions of injected embryos, probably due to loss of vessel integrity and
maintenance (Fig. S9). Our data suggest that pank2 could play a critical
role in junctional complex maturation, an important event for perme-
ability modulation and for correct formation of the vascular network..
4. Discussion
Model organisms provide an important platform for analysis of
human disease processes and development of therapies. The zebraﬁsh,
with a vertebrate biology, easy methods of genetic manipulation, and
speciﬁc brain regions that are conserved and comparable to human
counterparts, appears as a good model to study the pathophysiology
of human neurodegenerative disorders. In particular, the possibility to
investigate embryonic development may provide relevant insight into
the pathogenesis of disorderswith very early onset, asmany of those in-
cluded in the NBIA category. In this work, we provided the ﬁrst in vivo
functional characterization of pank2, the zebraﬁsh ortholog of human
PANK2, the gene mutated in PKAN, and documented its essential role
during vertebrate development. Zebraﬁsh Pank2 protein shows high
Fig. 7. Effects of P2-MO microinjection in transgenic lines Tg(neurod:EGFP) and Tg(neurod:EGFP-sox10:dsRed). Tg(neurod:EGFP) transgenic embryos were injected with ST-MO and P2-
MO and analyzed at the light (A) and ﬂuorescence microscope (B) at 48 hpf. Confocal analysis of transgenic line Tg(neurod:EGFP-sox10:dsRed) injected with ST-MO (C) and P2-MO at
48 hpf (D). Abbreviations: t, telencephalon; d, diencephalon, hv, hindbrain ventricle.
Fig. 8. pank2 knock-down is associated with increased cell death. AO staining of not injected- (B), ST-MO- (C) and P2-MO-injected (D) embryos (all displayed in full size in A) shows an
increased number of positive (dying) cells (white arrowheads) in pank2morphants, compared to controls. Other positive AOdomains, such as eye (e) and olfactory pits (op), are expected
at this developmental stage. All embryos are at 48 hpf, in lateral view, anterior to the left. Experiments were performed in duplicate, with at least 30 embryos per condition. The graph in E
shows the AO cell counting in the forebrain region of 5 embryos from each condition.
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Fig. 9. pank2 down-regulation alters expression of vascular endothelial cadherin 5. Cadherin 5 expression was analyzed by in situ hybridization in control embryos (A, C) and pank2
morphants (B, D) at 24 hpf. Lateral (A, B) and dorsal views (C, D). Abbreviations: DA, dorsal aorta; CV, cardinal vein; CtA, central arteries; BA, basilar aorta.
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about 120 amino acids present at the N-terminus of the human se-
quence, that was shown to contain the mitochondrial targeting signal
(Alfonso-Pecchio et al., 2012). Indeed, when expressed in mammalian
cell lines zebraﬁsh pank2 localizes in cytosol and nucleus. Due to the
lack of a zebraﬁsh speciﬁc antibody, we could not verify whether this
cellular localization represents the physiological condition in the ﬁsh.
In silico analysis of human, mouse, and zebraﬁsh amino acid sequences
performedwith TargetP andWolf PSORT indicate a clear mitochondrial
localization exclusively for the human protein. Interestingly, also the
mouse protein lacks the N-terminal sequence of the human mitochon-
drial isoform, but according to some studies (Johnson et al., 2004;
Brunetti et al., 2012), it localizes in the mitochondria. If conﬁrmed, the
difference in cellular distribution could be an indication of selective
properties characterizing the human enzyme. Nonetheless, human
and zebraﬁsh genes share the important and conserved feature ofFig. 10.pank2knock-downaffects trunk vessel integrity.WISH analysis of ﬂi1a expression at 26 h
MO (C) and P2-MO (D) in Tg(gata1a:dsRed-ﬂi1a:EGFP) embryos and analyzed the phenotype
intersegmental vessels..being expressed at high levels in brain and particularly in neurons, as
shown by qRT-PCR and WISH analysis, which makes the zebraﬁsh
model a relevant system to investigate pank2 function anddevelopmen-
tal role, with potential outcomes for comprehension of PKAN pathogen-
esis. Interestingly enough, the in situ hybridization decorated also cells
of the ependymal layer and gave an intense, speciﬁc signal also in
main axial vascular structures (dorsal aorta and cardinal vein), ﬁndings
that could indicate novel tissues and pathways potentially affected by
Pank2 defects. The gene shows a clearmaternal contribution at early de-
velopmental stages; indeed, it is already present at lower levels at 256-
cell stage and it is then maintained up to 24 hpf. Later on, it raises to
higher levels at 48 and 72 hpf. The loss-of-function studies, using the
morpholino approach, conﬁrmed WISH data and evidenced a relevant
role for pank2 in development of CNS and vascular structures. Signiﬁ-
cant edema in the midbrain/hindbrain ventricle and a severe perturba-
tion of brain morphology appeared at 24 hpf and worsened at 48 hpf.pf in ST-MO- and P2-MO-injected embryos (A, A’, B, B’).We injected 1 pmol/embryo of ST-
by confocal microscopy at 40 hpf. Abbreviations: DA, dorsal aorta; CV, caudal vein; ISVS,
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cephalon and diencephalon as shown by WISH with wnt1 and neurog1
neural marker riboprobes and by the ﬂuorescent pattern in
Tg(neurod:EGFP-sox10:dsRed) line exposed to P2-MO. Our cell death
and proliferation assays point to a major role for cell loss, compared to
decreased mitosis, in the determination of the observed phenotypes.
This could indicate that pank2 function is required for normal develop-
ment and maintenance of neurons in these brain areas and is of poten-
tial interest for PKAN pathology, that speciﬁcally affects the globus
pallidum. In adult ﬁsh, telencephalon, and particularly the ventral
zone contains brain nuclei proposed to be homologous to vertebrate
subpallium, including the pallidum (Northcutt, 1981; Northcutt, 1995;
Ganz et al., 2012). Since neurod is mostly expressed in dorsal telenceph-
alon, we cannot infer from our data the presence and role of pank2 in
pallidal neurons; application of other more speciﬁc neural markers
such as nkx2.1b, lsl and lhx1bwould be required to drawmore deﬁnitive
conclusions (Ganz et al., 2012). Histological sections also revealed ex-
pression of pank2 in ependymal cells at 24 and 48 hpf, and the hydro-
cephalus we observed in pank2morphants could be related to defects
in this type of cells and inmaintenance of midbrain–hindbrain ventricle
structure. Many proteins involved in iron metabolism are expressed in
ependymal layer (Benkovic and Connor, 1993; Siddappa et al., 2002)
and blood brain barrier (Moos, 2002; McCarthy and Kosman, 2015),
where they play an important role in controlling iron transport to and
from the brain. As we suggested previously (Poli et al., 2010), defects
in PANK2 in these type of cells could result inmodiﬁcation of expression
of iron-related proteins, and particularly of ferroportin, the sole cellular
iron exporter (Ganz, 2005), and hence shift iron homeostasis in brain
toward iron accumulation, one of the main neuropathological feature
of PKAN disorder.
Our data also indicate a role of pank2 in the formation of vessels and
maintenance of their integrity since all vascular markers we considered
in WISH and the transgenic lines we used in MO experiments indicate
severe defects in vascular arborization. In wild-type embryos the caudal
vein forms a venous plexus with a reticular pattern (Fig. 9A) and dorsal
aorta and cardinal vein are correctly lumenized (Fig. 10C). In most
morphants there is a cavernous caudal vein with loss of usual reticular
pattern, main axial vessels are fenestrated and the caliber is probably
enlarged; moreover, blood ﬂow is severely impaired despite a pumping
heart and intervein vessels are largely incomplete, ﬁndings consistent
with the observed caudal edema and hemorrhages. These observations
are completely novel and never documented in existing PKAN animal
models or in patients; hence their relevance for the function of the
human PANK2 and PKAN pathology is difﬁcult to predict. Our unpub-
lished observations show that PANK2 is expressed at signiﬁcant levels
in human umbilical vein endothelial (HUVEC) cells. We are currently
exploringwhether its down-regulation in this cell type could lead to de-
fects in angiogenesis. To this regard, an interesting communication by
Hayﬂick (2006) reported vascular changes in brains from PKAN pa-
tients, as detected by histochemistry. If conﬁrmed, this observation
would represent an important connection with the phenotype we
found in P2-MO-injected ﬁsh, and would solicit further investigation
of underlying molecular mechanisms.
Since we could observe embryos with clear alteration of the neural
structures and limited perturbation of the vascular development, as
well as embryoswith the opposite features,we speculate that the neural
and vascular phenotypes develop in parallel as independent events. This
is in accordance with the WISH data showing signiﬁcant expression of
pank2 gene in both types of tissues. Yet, a better deﬁnition of this aspect
may only come from investigation of the phenotypes at the molecular
level, possibly with the use of transgenic lines targeting speciﬁc subsets
of cells and molecular pathways.
The phenotype we observed is speciﬁc as conﬁrmed by the rescue
we obtained when pank2mRNAwas co-injected with P2-MO. This sug-
gests that, same as in humans and mice, the other gene paralogs
(pank1a, pank1b and pank4) present in zebraﬁsh do not compensatefor pank2 suppression. Very little and only preliminary information is
available about these genes in zebraﬁsh: according to WISH data pres-
ent in the ZFIN database (http://www.zﬁn.org), during embryonic de-
velopment pank1a is expressed in CNS and retina, while pank1b in
CNS, retina, and pronephric duct. None of them is present in vascular
structures, yet they share with pank2 the CNS localization. To assess
whether down-regulation of pank2 altered expression levels of these al-
ternate isoforms we quantiﬁed the amount of pank1a and pank1b
mRNAs by RT-PCR in ST-MO- and P2-MO-injected embryos at 24 hpf.
We did not ﬁnd any difference in pank1b levels at 24 hpf between the
two type of samples, while we could not amplify pank1a in any sample
at 24 hpf, even though the RT-PCR did work with 2 cell-stage embryos.
Altogether we can conclude that the phenotype we obtained by pank2
down-regulation is speciﬁc and indicate that difference in function
and/or distribution among the existing forms of Pank enzyme preclude
signiﬁcant compensatory effects during zebraﬁsh development. Of great
relevance is also the restoration of thewild type phenotypewe obtained
by exposing P2-MO-injected embryos to 30 μM pantethine. The drug
was shown to rescue the phenotype due to PANK2 defects in mamma-
lian cells (Rana et al., 2010; Siudeja et al., 2012), in Pank2 knock-out
mice (Brunetti et al., 2014) and in fumble Drosophila mutants and cell
lines (Rana et al., 2010; Siudeja et al., 2012). The mechanism of action
of pantethine is not clear. Bosveld et al. (2008) suggested that in Dro-
sophila it could circumvent the block in CoA biosynthesis due to the
lack of phospho-pantothenate, the product of PANK2 activity, beingme-
tabolized ﬁrstly to pantetheine (Durr and Cortas, 1964; Fisher and Szulc,
1997) and then to phospho-pantetheine, an intermediate of CoA bio-
synthesis downstream of PANK2 activity. Yet the alternative enzyme
catalyzing pantetheine phosphorylation is not known. There is evidence
that in humans and rodents pantethine is readily metabolized by
pantetheinase to cysteamine and pantothenate (Wittwer et al., 1985;
Kaskow et al., 2012), compounds that cannot provide a biochemical by-
pass for the blockage of CoA biosynthesis. Since cysteamine was able to
reproduce the lipid-lowering effect obtained by pantethine administra-
tion to human fetal ﬁbroblasts or rabbits and rats (Wittwer et al., 1987)
and was shown to have important neuroprotective effects in models of
Parkinson's disease (Sun et al., 2010; Gibrat and Cicchetti, 2011) and
Huntington's disease (Borrell-Pagès et al., 2006), it is possible that
pantethine effect in mice is at least in part mediated by this metabolite.
Interestingly, neither cysteamine nor pantothenate could reproduce the
increase of about 50% in liver CoA concentration observed in rats treated
with pantethine (Wittwer et al., 1987), suggesting the possible exis-
tence of multiple mechanisms contributing to the capacity of the drug
for correcting defects related to PANK2 malfunctioning. We could not
measure CoA levels in the zebraﬁsh embryos and hence have no direct
evidence of a link between the phenotype we observed and the short-
age of CoA. Nonetheless, the high efﬁcacy of pantethine treatment let
infer this interpretation, that is more strongly supported by the result
we obtained by addition of CoA to the water of P2-MO injected-
embryos. The compound fully prevented the development of the abnor-
mal phenotype, while vitamin B5 was not effective. We speculate that
addiction of CoA to water restores normal levels of the metabolite in
the embryos and therefore prevents the effects due to the injection of
pank2 morpholino. This is important evidence that the down-
regulation of pank2 in zebraﬁsh alters conservedmolecularmechanisms
and pathways and hence the model can be useful to both investigate
PKAN pathogenesis and perform screening for molecules with thera-
peutic potential.
5. Conclusion
We have investigated the expression and function of pank2 during
early stages of zebraﬁsh development. There is so far no information
about the role of this enzyme in vertebrate development and, given
the early onset ofmost PKAN cases, this study could be helpful to under-
stand the disease pathogenesis. Our results suggest that pank2
47D. Zizioli et al. / Neurobiology of Disease 85 (2016) 35–48downregulation is associated with shortage of CoA in speciﬁc sets of
cells and tissues, that in turn impairs the development of different re-
gions in the forebrain, and disrupts normal vascular arborization. It
will be important to deﬁne the subset of affected neural cells, since
this could be related to the selective vulnerability of the globus pallidum
in PKAN patients. More difﬁcult is to connect the unpredicted role of
pank2 in the formation of vascular structures to PKAN clinical features
and pathogenesis, and further work is needed to conﬁrm this aspect in
different experimental models. The availability of different transgenic
lines for speciﬁc signaling cascades (Moro et al., 2013) and the possibil-
ity to generate pank2 knock-out/knock-in models will allow a thorough
characterization of the affected cell types and involved biochemical
pathways, thus providing essential details for PKAN comprehension
and treatment.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nbd.2015.10.010.
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